Squarepoint’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.03M Buy
190,900
+164,400
+620% +$2.55M ﹤0.01% 2001
2026
Q1
$358K Buy
+26,500
New +$371K ﹤0.01% 3572
2025
Q4
Sell
-18,600
Closed -$184K 4956
2025
Q3
$184K Buy
+18,600
New +$181K ﹤0.01% 3972
2025
Q1
Sell
-20,000
Closed -$249K 5495
2024
Q4
$249K Buy
+20,000
New +$246K ﹤0.01% 4303
2021
Q3
Sell
-300,200
Closed -$4.29M 3474
2021
Q2
$4.29M Buy
300,200
+200
+0.1% +$2.89K 0.02% 793
2021
Q1
$4.19M Buy
+300,000
New +$4.89M 0.02% 707

Other funds holding VTRS

Squarepoint's VTRS Position: Q2 2026 in Review

Squarepoint reduced its Viatris (VTRS) stake by 96% in Q2 2026, selling an estimated $33.7M and leaving 98,356 shares worth $1.56M. The position accounts for ﹤0.01% of the portfolio, ranked #2532.

Squarepoint first reported a position in VTRS in Q3 2015 and has held it in 38 quarters since. The position peaked at $30.7M in Q1 2026. 1,028 funds tracked by Wall St. Rank hold VTRS as of Q2 2026.

  • Squarepoint held 98,356 shares of Viatris worth $1.56M as of Q2 2026.
  • Squarepoint sold 2,175,243 Viatris shares in Q2 2026, an estimated $33.7M.
  • Viatris made up ﹤0.01% of Squarepoint's portfolio in Q2 2026, its #2532 holding.
  • Squarepoint first reported a position in Viatris in Q3 2015 and has held it in 38 quarters since.
  • Squarepoint's Viatris position peaked at $30.7M in Q1 2026.
  • 1,028 funds tracked by Wall St. Rank held Viatris as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.